Bioavailablility of rifampicin in a separate formulation and fixed dose combination with iosniased NIH: a case for a fixed dose combination (FDC) for the treatment of tuberculosis
- 1 June 1999
- journal article
- clinical trial
- Published by African Journals Online (AJOL) in Central African Journal of Medicine
- Vol. 45 (6) , 141-4
- https://doi.org/10.4314/cajm.v45i6.8472